These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Angiotensin converting enzyme in the Parkinsonian brain. Rinne UK; Koskinen V; Laaksonen H; Tenovuo O Ann Neurol; 1978 Nov; 4(5):483. PubMed ID: 216304 [No Abstract] [Full Text] [Related]
7. Cerebrospinal fluid angiotensin converting enzyme levels in the diagnosis of neurosarcoidosis. Jones DB; Mitchell D; Horn DB; Edwards CR Scott Med J; 1991 Oct; 36(5):144-5. PubMed ID: 1664971 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis. Kawajiri M; Mogi M; Higaki N; Matsuoka T; Ohyagi Y; Tsukuda K; Kohara K; Horiuchi M; Miki T; Kira JI Mult Scler; 2009 Feb; 15(2):262-5. PubMed ID: 19136547 [TBL] [Abstract][Full Text] [Related]
9. Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia. Wahlbeck K; Ahokas A; Miettinen K; Nikkilä H; Rimón R Schizophr Bull; 1998; 24(3):391-7. PubMed ID: 9718631 [TBL] [Abstract][Full Text] [Related]
10. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Dale JC; O'Brien JF Mayo Clin Proc; 1999 May; 74(5):535. PubMed ID: 10319092 [No Abstract] [Full Text] [Related]
11. Elevated plasma vasopressin and normal cerebrospinal fluid angiotensin-converting enzyme in chronic pain disorder. Wahlbeck K; Sundblom M; Kalso E; Tigerstedt I; Rimón R Biol Psychiatry; 1996 Nov; 40(10):994-9. PubMed ID: 8915558 [TBL] [Abstract][Full Text] [Related]
12. The angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson's disease. Su G; Dou H; Zhao L; Wang H; Liu G; Huang B; Peng B J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):428-33. PubMed ID: 23833036 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme in cerebrospinal fluid: a new assay. Oksanen V; Fyhrquist F; Somer H; Grönhagen-Riska C Neurology; 1985 Aug; 35(8):1220-3. PubMed ID: 2991815 [TBL] [Abstract][Full Text] [Related]
14. Molecular heterogeneity of angiotensin converting enzyme in human cerebrospinal fluid. Lantz I; Nyberg F; Terenius L Biochem Int; 1991 Mar; 23(5):941-8. PubMed ID: 1715707 [TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease. Lin JJ; Yueh KC; Lin SZ; Harn HJ; Liu JT J Neurol Sci; 2007 Jan; 252(2):130-4. PubMed ID: 17196621 [TBL] [Abstract][Full Text] [Related]
16. The insertion/deletion polymorphism in the angiotensin-converting enzyme and susceptibility to schizophrenia or Parkinson's disease: A meta-analysis. Song GG; Lee YH J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):434-42. PubMed ID: 25143327 [TBL] [Abstract][Full Text] [Related]
17. CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunity. Matsushita T; Isobe N; Kawajiri M; Mogi M; Tsukuda K; Horiuchi M; Ohyagi Y; Kira J J Neurol Sci; 2010 Aug; 295(1-2):41-5. PubMed ID: 20541774 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of L-dopa-induced adverse effects. Pascale E; Purcaro C; Passarelli E; Guglielmi R; Vestri AR; Passarelli F; Meco G J Neurol Sci; 2009 Jan; 276(1-2):18-21. PubMed ID: 18805557 [TBL] [Abstract][Full Text] [Related]
19. Determining the Enzymatic Activity of Angiotensin-Converting Enzyme 2 (ACE2) in Brain Tissue and Cerebrospinal Fluid Using a Quenched Fluorescent Substrate. Sriramula S; Pedersen KB; Xia H; Lazartigues E Methods Mol Biol; 2017; 1527():117-126. PubMed ID: 28116711 [TBL] [Abstract][Full Text] [Related]